Skip to main content
Premium Trial:

Request an Annual Quote

Waters Q3 Revenues Up, Income Down

NEW YORK, Oct. 22 (GenomeWeb News) - Waters reported revenues of $230.4 million for the third quarter today, up from $216.0 million for the same period last year.


The Milford, Mass., instruments company had net income of $36.4 million, compared to $39.0 million for the same period last year.


For the quarter, R&D expenses increased to $15.1 million, from $13.6 million in the same period last year.


The company said its results for the quarter include "restructuring and other incremental costs and adjustments recorded in relation to the Company's reorganization of the HPLC and mass spectrometry businesses, and restructuring charges relating to the acquisition of the rheology business of Rheometric Scientific." Additionally, they reflect charges for in-process R&D that relate to the acquisition of Creon Lab Control, the company said.


As of Sept. 30, Waters had $288.1 million in cash and cash equivalents, up from $263.3 million at the end of 2002.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.